About Us

Improving health through innovation in rapid diagnostic testing

Abingdon Health believes innovation in rapid testing is integral to the future of improving health outcomes for humans, animals, plants and the environment.

Our clients’ ambitions are at the heart of our business. Therefore, we deploy a multi-disciplinary team approach to lateral flow assay development and manufacture that integrates innovation, quality, process, technical skill and regulatory expertise.

We form long-term partnerships with our customers that draw on our many years of lateral flow assay and reader experience and their industry expertise. This approach produces rapid assays that make a difference to our customers’ businesses and their clients.

Abingdon Health’s lateral flow assay and reader services operate under ISO 13485, ISO 9001 and work to GMP.

Our promise:

• Produce rapid diagnostics tests that improve the health outcomes of animals, humans and plants.
• Provide best-in-class, customer-focused lateral flow assay development and manufacturing services.
• Innovate to provide state-of-the-art diagnostic solutions that support customer, end-user and market needs.